mega trends 2022
What’s Ahead for 2022: The Three Mega-Trends to Watch

2021 was a year of exploration as companies tried to deal with the ongoing COVID crisis.

| Blog | Industrials Healthcare & Life Sciences Consumer Financial Services Technology, Media & Telecom Commercial Strategy & Pricing Consulting
hidden champions
Hidden Champions: A new species in the making

From thumbtack, bolt, and passport manufacturers, to multipack carriers Germany has a long history of generating businesses so niche that they immediately achieve global dominance in their sectors.

| Perspective | Whitepaper | Automotive
Insights on Inflation Management for Distributors

Listen in as Simon-Kucher Partner, William Humsi, provides his insight on inflation management on a podcast hosted by MDM.

| Press Release
Overdraft Fee Strategies for Financial Institutions

Listen in as Simon-Kucher partners, Leo D'Acierno and Betty Cowell, discuss overdraft fee strategies for financial institutions in a podcast hosted by American Banker.

| Press Release
Pricing Strategy for Inflation

Are you dealing with inflation and market volatility?

| Press Release
US Health Policy
US Health Policy Update: Important Provisions of the Build Back Better Act

The recent Build Back Better Act presents an opportunity to completely change the healthcare market landscape in the US if certain provisions make it through the Senate.

| Blog | Healthcare & Life Sciences Customer, Product & Market Strategy Pricing Strategy & Revenue Management
pharmaceutical drug prices
Chile: New Laws and Regulations Controlling Pharmaceutical Drug Prices

The CENABAST law and the “Drugs 2” bill will have a serious effect on the Chilean pharmaceutical industry.

| Blog | Healthcare & Life Sciences Customer, Product & Market Strategy Pricing Strategy & Revenue Management
patient access
China Implements Dual-Channel Policy to Improve Patient Access to Drugs

China’s new dual-channel policy will have a serious impact on how manufacturers deal with pharmacies and hospitals in the country.

| Blog | Healthcare & Life Sciences Customer, Product & Market Strategy
optimizing market access
MEB-ZIN Parallel Procedure: Optimizing Market Access in the Netherlands

In this brief we explore the introduction and implications of the MEB-ZIN Parallel Procedure pilot, which was launched in 2019 in the Netherlands.

| Blog | Healthcare & Life Sciences Customer, Product & Market Strategy
innovation drugs Spain
Funding for Early Innovation Drugs Slows Down in Spain

The approval for early innovation products is gaining momentum throughout the EU.

| Blog | Healthcare & Life Sciences Customer, Product & Market Strategy
Language
Search